← Leaderboards
Rachel R Luba
Columbia University Health Sciences
$360,720
Attributed
$360,720
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $180.4K · FY2024–25$200K$150K$100K$50K$0
'24
'25
Funding mix
By agency
NIH$360,720 · 1
By mechanism
K23$360,720 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Adam Mariusz Bisaga$21,349,874
- Edward V Nunes$88,947,598
- Sabina Hirshfield$4,641,038
- Kara Elizabeth Rudolph$5,546,220
- Carlos Blanco$12,631,998
Others in their field
Other Rising Stars on “Admission Activity”
- John Alam · Eip Pharma, Inc.$10,536,018
- Gary Lessing · Inovodel, Inc.$2,946,822
- Lorraine I Kelley-Quon · Children'S Hospital Of Los Angeles$2,495,528
- Joseph Shapiro · National Bureau Of Economic Research$2,440,931
- Katherine Hoops · Johns Hopkins University$2,401,338
- Timothy William Dunn · Duke University$2,387,866
Research focus
Admission ActivityAdoptionAdultApplications GrantsAutomobile DrivingBackBiological FactorsBiological MarkersBody FatBody WeightBuprenorphineCareerCareer DevelopmentClinical TrialsConduct Clinical TrialsCravingData AnalysesDedicationsDependenceDesignDoseDropoutDrug KineticsAbstinence
Grant awards (2)
A Randomized Controlled Trial Examining Extended-Injectable Buprenorphine in those who use High Potency Synthetic Opioids$180,360
K23 · FY2025 · DA · contact PI
A Randomized Controlled Trial Examining Extended-Injectable Buprenorphine in those who use High Potency Synthetic Opioids$180,360
K23 · FY2024 · DA · contact PI